share_log

Rallybio Initiates Phase 2 Trial Of RLYB212 To Address HPA-1a Alloimmunization And FNAIT In Pregnant Women, With Screening Underway Across European Sites For Target Enrollment Of Eight Participants

Benzinga ·  Nov 21, 2024 21:08
Rallybio Initiates Phase 2 Trial Of RLYB212 To Address HPA-1a Alloimmunization And FNAIT In Pregnant Women, With Screening Underway Across European Sites For Target Enrollment Of Eight Participants
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment